647 filings
Page 2 of 33
8-K
LPCN
Lipocine Inc
26 Oct 23
Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum Depression
9:35am
8-K
LPCN
Lipocine Inc
23 Oct 23
Other Events
8:52pm
8-K
LPCN
Lipocine Inc
6 Oct 23
Termination of a Material Definitive Agreement
4:05pm
8-K
LPCN
Lipocine Inc
19 Sep 23
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
4:10pm
8-K
LPCN
Lipocine Inc
10 Aug 23
Other Events
8:35am
10-Q
2023 Q2
LPCN
Lipocine Inc
Quarterly report
10 Aug 23
8:31am
8-K
LPCN
Lipocine Inc
27 Jul 23
Other Events
6:45am
8-K
LPCN
Lipocine Inc
26 Jun 23
Other Events
9:20am
8-K
LPCN
Lipocine Inc
26 Jun 23
Other Events
9:15am
8-K
LPCN
Lipocine Inc
23 Jun 23
Other Events
4:19pm
8-K
LPCN
Lipocine Inc
14 Jun 23
Lipocine to Present at H.C. Wainwright Annual Neuropsychiatry Virtual Conference
8:15am
8-K
LPCN
Lipocine Inc
7 Jun 23
Lipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023
8:15am
8-K
LPCN
Lipocine Inc
31 May 23
Other Events
4:49pm
4
Mahesh V. Patel
25 May 23
Lipocine / Mahesh V. Patel ownership change
3:10pm
8-K
LPCN
Lipocine Inc
16 May 23
Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine’s Oral Candidate for Rapid Relief of Depression
7:00am
4
LPCN
Lipocine Inc
12 May 23
Lipocine / Spyros Papapetropoulos ownership change
4:37pm
4
Higuchi John W.
12 May 23
Lipocine / John W. Higuchi ownership change
4:36pm
4
Ono Richard Dana
12 May 23
Lipocine / Richard Dana Ono ownership change
4:35pm
4
Jill M. Jene
12 May 23
Lipocine / Jill M. Jene ownership change
4:34pm
4
Fink Jeffrey Arvin
12 May 23
Lipocine / Jeffrey Arvin Fink ownership change
4:33pm